Luke Fletcher

Hematologist/Oncologist, myeloid disease expert at Willamette Valley Cancer Institute

[Luke Fletcher @LFletcherMD15]

@arpitapgandhi so proud of Brian and his heart to advocate and help others. so glad to be a part of his AML team

[Luke Fletcher @LFletcherMD15]

Honored to be on this guidelines committee for elderly AML. https://t.co/8YVKGOOiOd

[WolverHeme @WolverHeme]

Come have a 🍺 or ☕️ and join @ajperissinotti, @Berninini, and special guest Dr. Luke Fletcher @LFletcherMD15 in our discussion of innovations and best practices in community hematology! https://t.co/vu5U3k3ZYd

[Oregon Football @oregonfootball]

Game 5: "Stomp Out Cancer"

Watch Full Video:
https://t.co/YMa2lgue7N

#GoDucks

[Luke Fletcher @LFletcherMD15]

@AaronGoodman33 The tables a littl wonky. States iron defiicency ferritin <30 but ida is ferritin <12. Definitely 30 for both, seen tons of consults for anemia and patient told iron is ok cause ferritin is 15 and after iron replacement counts totally normal

[Luke Fletcher @LFletcherMD15]

@AaronGoodman33 Not that this ever becomes approved, but think for a second how much of a nightmare this would be trying to obtain and patients take a regimen like this outside of a trial? 4 oral drugs, yikes

[Integrity CE SoMe CME @SoMeCME]

4/ 📽️ How will emerging agents change #myelofibrosis treatment❓ What AEs can be expected w/ emerging therapies❓

@AaronGerds will tell you all about it in the video below❗️

#MFBrief

https://t.co/onKwKgdhbt

[Integrity CE SoMe CME @SoMeCME]

2/ How do you manage anemia in patients w/ #myelofibrosis & will your approach change w/ approval of MMB❓ #MFBrief

✍️ Agents w/ spleen, symptom, & anemia benefit
Luspatercept: ⬆️ TI & durable response
Momelotinib: ⬆️ TI & ⬇️ anemia
Pacritinib: ⬆️ TI

[Integrity CE SoMe CME @SoMeCME]

3/ 📊 What treatment would you select for a 75yo patient w/ #myelofibrosis & Hgb 8.8 g/dL who is receiving RUX 5 mg BID❓
#MFBrief

[Integrity CE SoMe CME @SoMeCME]

Don't miss the final #MFBrief in this series TODAY!

💬 SOC & emerging treatment options for patients w/ #myelofibrosis
👥 @AaronGerds, @LFletcherMD15, @KuykendallMd, & @RaajitRampal
🕓 4:00 PM EST
📅 https://t.co/q3I7joIhWU

#MedEd #FOAMed #MedTwitter

[Luke Fletcher @LFletcherMD15]

@SoMeCME This is exactly type of patient I would consider switching. Ruxolitinib at 5mg BID does not have good efficacy for treating myelofibrosis (mainly just mild anti-inflammatory effect)

[Integrity CE SoMe CME @SoMeCME]

6/ We hope you enjoyed this #myelofibrosis education❗️

Complete the posttest & evaluation here 👉🏼 https://t.co/jr6NozsYkt
& claim your 🆓 CME❗️
If you missed #MFBrief1 👉🏼 https://t.co/yzgKlycyDQ
If you missed #MFBrief2 👉🏼 https://t.co/lokpGcJscX

[Integrity CE SoMe CME @SoMeCME]

5/ 📊 What treatment would you select for a 75yo patient w/ #myelofibrosis & Hgb 8.8 g/dL who is receiving RUX 5 mg BID❓

#MFBrief

[Integrity CE SoMe CME @SoMeCME]

1/ #MFBrief

SOC & emerging treatment options for patients w/ #myelofibrosis w/ @AaronGerds, @LFletcherMD15, @KuykendallMd, & @RaajitRampal

Supported by an educational grant from GSK.

CME ℹ️ https://t.co/Oa0QAqfyyN

📊 What is your specialty/degree❓

[Luke Fletcher @LFletcherMD15]

@TalhaBadarMD @SoMeCME Important point, use what you have and can get, but push to get best risk stratification you can. Also, can refine as information comes in as well.

[Luke Fletcher @LFletcherMD15]

@Vikas_Gupta_1 @SoMeCME @AaronGerds @RaajitRampal @drsangeetmd @doctorpemm In case by case basis but yes I do

[Integrity CE SoMe CME @SoMeCME]

1/ #MFBrief

Effect of prognostic factors on choice of treatment for patients w/ #myelofibrosis w/ @AaronGerds, @LFletcherMD15, @TalhaBadarMD, & @Vikas_Gupta_1

Supported by an educational grant from GSK.

CME ℹ️ https://t.co/F3X79chmEc

📊 What is your specialty/degree❓

[Luke Fletcher @LFletcherMD15]

@SoMeCME @AaronGerds Pragmatically, @doctorpemm @AaronGerds @TalhaBadarMD Any issues getting approvals for NGS of blood for patients if unable to get off bone marrow biopsies to allow stratification?

[Integrity CE SoMe CME @SoMeCME]

6/ We hope you enjoyed this #myelofibrosis education❗️

Complete the posttest & evaluation here 👉 https://t.co/ldr8NN1TZ4
& claim your 🆓 CME!

🗓️ Don’t miss the next #MFBrief on Wednesday, Nov 15 @ 4:00 PM EDT w/ @AaronGerds, @LFletcherMD15, @KuykendallMd & @RaajitRampal❗️

[Integrity CE SoMe CME @SoMeCME]

5/ 📊 What DIPSS risk group would you assign to a 75 yo patient w/ myelofibrosis, unintentional weight loss, fever/night sweats, anemia (Hgb 8.8 g/dL), adequate platelets (211 K/μL), & 2% circulating blasts❓
#MFBrief